These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2050662)
1. Implications of invariant residue LeuB6 in insulin-receptor interactions. Nakagawa SH; Tager HS J Biol Chem; 1991 Jun; 266(18):11502-9. PubMed ID: 2050662 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Nakagawa SH; Tager HS; Steiner DF Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908 [TBL] [Abstract][Full Text] [Related]
3. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. Nakagawa SH; Tager HS J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607 [TBL] [Abstract][Full Text] [Related]
4. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Nakagawa SH; Tager HS Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705 [TBL] [Abstract][Full Text] [Related]
5. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation. Mirmira RG; Tager HS J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499 [TBL] [Abstract][Full Text] [Related]
6. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes. Cara JF; Nakagawa SH; Tager HS Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179 [TBL] [Abstract][Full Text] [Related]
7. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. Mirmira RG; Nakagawa SH; Tager HS J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428 [TBL] [Abstract][Full Text] [Related]
8. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. Nakagawa SH; Tager HS J Biol Chem; 1989 Jan; 264(1):272-9. PubMed ID: 2642474 [TBL] [Abstract][Full Text] [Related]
9. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain. Nakagawa SH; Tager HS J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501 [TBL] [Abstract][Full Text] [Related]
10. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin. Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048 [TBL] [Abstract][Full Text] [Related]
11. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone. Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184 [TBL] [Abstract][Full Text] [Related]
12. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. Assoian RK; Thomas NE; Kaiser ET; Tager HS Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5147-51. PubMed ID: 6752939 [TBL] [Abstract][Full Text] [Related]
13. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872 [TBL] [Abstract][Full Text] [Related]
14. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design. Pandyarajan V; Smith BJ; Phillips NB; Whittaker L; Cox GP; Wickramasinghe N; Menting JG; Wan ZL; Whittaker J; Ismail-Beigi F; Lawrence MC; Weiss MA J Biol Chem; 2014 Dec; 289(50):34709-27. PubMed ID: 25305014 [TBL] [Abstract][Full Text] [Related]
15. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone. Chu YC; Zong L; Burke GT; Katsoyannis PG J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216 [TBL] [Abstract][Full Text] [Related]
16. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor. Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842 [TBL] [Abstract][Full Text] [Related]
17. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. Beyermann M; Fechner K; Furkert J; Krause E; Bienert M J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516 [TBL] [Abstract][Full Text] [Related]
18. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin. Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179 [TBL] [Abstract][Full Text] [Related]
19. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine. Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084 [TBL] [Abstract][Full Text] [Related]
20. Evidence supporting a two-receptor model for insulin binding by cultured embryonic heart cells. Wheeler FB; Santora AC; Elsas LJ Endocrinology; 1980 Jul; 107(1):195-207. PubMed ID: 6991248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]